Welcome to the Laboratory of Bioequivalence and Molecular Biology

The Laboratory of Bioequivalence and Molecular Biology is dedicated to combine its extensive expertise in Clinical Research in Argentina and Latin America according to GCP with the use of efficient and automated laboratory practices (GLP) offering to the medical and pharmaceutical community all around the world strategic solutions for the development of health services and products, contributing to protect and to improve health care.

Our commitment to offer a high-quality service in compliance with national and international regulatory guidelines, assures you that you will get excellent and reliable results in an efficient and timely manner.

What do we offer?

At the Laboratory of Bioequivalence and Molecular Biology we perform In Vivo Bioequivalence developing and validating fast and sensitive HPLC-UV methods for the quantization of drugs in human plasma, offering the possibility to use other detection methods according to the needs of the compounds and the protocol.

At the Center of Biomedical Research (CIB), we provide comprehensive services in the design, execution and follow up of In vivo Bioequivalence trials, as well as in national and international phase I-IV studies according to ANMAT, FDA, ICH, GCP guidelines.

On the other side, we offer to the medical and scientific community the possibility to perform Therapeutic Drug Monitoring (TDM) in HIV+ patients (AIDS) undergoing highly active antiretroviral therapies (HAART) and who are suspected to present viral resistance, therapeutic failure or toxicity associated with antiretroviral drug plasma levels out of the therapeutic range.

The Laboratory of Bioequivalence and Molecular Biology has been audited by the National Institute of Medicaments (INAME) for bioequivalence assays that were approved by the National Agency of Medicaments, Aliments and Medicinal Technology (ANMAT) and it complied with all quality requirements. Member of the International Association of Therapeutic Drug Monitoring & Clinical Toxicology (IATDMCT)

Laboratory of Bioequivalence and Molecular Biology
French 2464
C1125AAH - Ciudad de Buenos Aires 


ARGENTINA
Tel/Fax: 54 11 4576-6060, int 22
Email: bioequivalencia@bioequivalencia.com.ar

Revision: January 21st, 2005
Hosting: www.argentinavirtual.net